Plasmolifting™ is looking to boost its working capital and has partnered with TFGcrowd toward that end. Specifically, they are looking for funding that would help them get over the costs related to their production and distribution. That being the case, their minimum target is to raise 150’000€, with a total target of 200’000€ and are willing to grant interested investors with a substantial annual interest rate of 18% for their trust. All backers will be paid their dues monthly over the course of the loan term, which will be six months.
The following pledges secure the loan:
• A pledge on Plasmolifting™
• Personal guarantee of the Borrowers’ shareholders & CEO
• Guarantee of the Borrower
The loan is offered with the BuyBack Guarantee: thus, if a borrower is late with the repayment of the loan, TFGcrowd will compensate the investors both the invested principal amount and interest, as well as pay the accrued interest after 60 days of delay.
You can’t go wrong with Plasmolifting™ as your next best investment!
The Plasmolifting™ company is the official representative of Plasmolifting in the UK. It offers high-level products with all the certificates for sale in the EU. It has its own sales department and organizes training with highly qualified doctors around the world.
- It's a fast-growing company that has created a vast distribution network in the Russian Federation and CIS countries.
- Provides training to health professionals wishing to use our technology in their clinical practice.
- Has carried out numerous clinical studies evaluating the safety and efficacy of the Plasmolifting technology.
Now the company is ready to share their experience with health professionals who wants to use Plasmolifting™ technology in their everyday practice.
Plasmolifting™ aims to make autologous plasma injections a routine, effective and safe method of biological stimulation of pathophysiological processes.
Plasmolifting™ method is well known around the world and takes place not only in aesthetic medicine but also in neurology, trichology, dentistry, orthopedics, sports medicine, urology, and gynecology.
The use of specialized high-quality vacuum tubes is one of the key factors in ensuring the efficacy and safety of the procedure performed with our technology. The tubes distributed by Plasmolifting company allow obtaining high-purity autologous plasma with therapeutic properties, significantly increasing treatment efficacy.
The materials used for manufacturing the Plasmolifting™ tubes and the substances contained therein enable the production of autologous plasma suitable for injection into the human body; the upper and middle parts of the inner wall of the tube are lined with a thin layer of anticoagulant.